Genertec Universal Medical Group Company Limited

Genertec Universal Medical Group Company Limited

0.53
EUR
0.00
(0.00%)
1.02BMarket Cap
Mar 31Next Earn

Total Valuation

EUR

As of June 30, 2026, Genertec Universal Medical Group Company Limited carries a market capitalization of 1.02B, placing it among publicly traded companies globally. Its enterprise value stands at 7.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.02B
Enterprise Value7.61B

Important Dates

Genertec Universal Medical Group Company Limited's next confirmed earnings release is scheduled for March 31, 2027.

Earnings Date3/31/2027

Share Statistics

As of June 30, 2026, Genertec Universal Medical Group Company Limited has 2.01B shares outstanding.

Shares Outstanding2.01B

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio0.36
P/TBV Ratio0.38

Financial Position

As of June 30, 2026, Genertec Universal Medical Group Company Limited maintains a current ratio of 1.24, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

Current Ratio1.24
Quick Ratio0.08
Debt / Equity191.82

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count23,791.00

Stock Price Statistics

EUR

As of the close on November 17, 2026, Genertec Universal Medical Group Company Limited's stock has declined approximately 24.29% over the past 52 weeks. The 50-day moving average sits at 0.51, while the 200-day moving average is 0.56.

52-Week Price Change-24.29%
50-Day Moving Average0.51
200-Day Moving Average0.56

Balance Sheet

EUR

As of June 30, 2026, Genertec Universal Medical Group Company Limited holds 319.67M in cash and equivalents against 6.38B in total debt, resulting in a net debt position of 5.98B. Total book value stands at 2.79B, with working capital of 1.01B providing operational flexibility.

Cash & Cash Equivalents319.67M
Total Debt6.38B
Net Debt5.98B
Equity (Book Value)2.79B
Book Value Per Share1.39
Working Capital1.01B